Pharma parent and spinoff are buys

ELI LILLY & CO. $115 (New York symbol LLY; Manufacturing & Industry sector; Shares outstanding: 920.8 million; Market cap: $105.9 billion; Dividend yield: 2.2%; Takeover Target Rating: Low; www.lilly.com) is a leading developer of prescription drugs. Its top-selling products include Humalog (diabetes), Alimta (lung cancer) and Cialis (erectile… Read More